Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05440318 · ClinicalTrials.gov registry record
Use of Wearable Digital Sensors After mRNA Vaccination in Adults
A clinical trial, sponsored by ModernaTX.
- Completed
- Registry status
- 62
- Enrollment target
NCT05440318 is a clinical trial that has completed, run by ModernaTX. The registered enrollment target is 62 participants.
The verdict
NCT05440318 has completed, sponsored by ModernaTX.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the physiological and behavioral impact of the immune response to vaccines after receipt of investigational or approved messenger ribonucleic acid (mRNA) vaccines using wearable medical sensors, with the potential of establishing a digital biomarker of vaccine response due to stimulation of the immune system.
Interventions
- DEVICE Wireless wearable digital devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2022-06-16 |
| Est. Completion | 2023-02-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05440318
The ClinicalTrials.gov registry entry for NCT05440318 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ModernaTX, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Wireless wearable digital devices is the first listed.
NCT05440318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05440318 about?
NCT05440318 is a clinical study titled "Use of Wearable Digital Sensors After mRNA Vaccination in Adults". The purpose of this study is to explore the physiological and behavioral impact of the immune response to vaccines after receipt of investigational or approved messenger ribonucleic acid (mRNA) vaccines using wearable medical sensors, with the potential of establishing a digital biomarker of vaccine...
What is the current status of trial NCT05440318?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2022-06-16. Estimated completion is 2023-02-07.
What interventions are being tested in trial NCT05440318?
The interventions under investigation include: Wireless wearable digital devices (DEVICE).
Who is sponsoring clinical trial NCT05440318?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.